| Financial Year |
March 31 2023 |
| Monetary Funds |
582,745,156.09 |
| Held-for-trading Financial Assets |
161,456,497.21 |
| Notes Receivable |
41,403,911.16 |
| Accounts Receivable |
273,272,475.27 |
| Advances to Suppliers |
90,362.04 |
| Other Receivables |
1,557,039.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
73,194,443.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
653,034.68 |
| Total Current Assets |
1,154,156,278.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
45,517,413.47 |
| Investment Properties |
-- |
| Fixed Assetes |
85,164,811.83 |
| Under-construction Projects |
325,071,895.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,179,476.20 |
| R&D expenses |
17,539,728.95 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
140,114.33 |
| Deferred Income Tax Assets |
15,116,292.86 |
| Other Non-Current Assets |
1,050,682.10 |
| Sub-Total of Non-Current Assets |
698,643,111.70 |
| Total Assets |
1,852,799,389.77 |
| Short-Term Loans |
14,890,625.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
43,694,911.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,057,699.86 |
| Taxes Payable |
11,239,694.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,066,026.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
128,104,194.93 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,535,679.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,792,996.61 |
| Total Liabilities |
138,897,191.54 |
| Paid-In Capital(Or Share Stock) |
269,548,349.00 |
| Capital Surplus |
1,054,905,377.62 |
| Surplus Reserve |
47,519,893.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
310,610,535.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,713,902,198.22 |
| Owner's Equity（Stockholder's Equity） |
1,713,902,198.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,852,799,389.77 |
